Co-Authors
This is a "connection" page, showing publications co-authored by Kyung Hong and Wonhwa Lee.
Connection Strength
2.220
-
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 11 17; 5(1):267.
Score: 0.914
-
PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials. 2021 06; 273:120827.
Score: 0.235
-
Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm. Nano Today. 2021 Jun; 38:101149.
Score: 0.235
-
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther. 2020 09 03; 5(1):186.
Score: 0.225
-
Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication. Infect Chemother. 2020 Sep; 52(3):396-402.
Score: 0.223
-
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study. Yonsei Med J. 2020 May; 61(5):431-437.
Score: 0.220
-
Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials. 2021 01; 267:120389.
Score: 0.057
-
Prognostic Accuracy of the SIRS, qSOFA, and NEWS for Early Detection of Clinical Deterioration in SARS-CoV-2 Infected Patients. J Korean Med Sci. 2020 Jun 29; 35(25):e234.
Score: 0.056
-
Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea. J Korean Med Sci. 2020 Jun 15; 35(23):e209.
Score: 0.055